A transdermal patch containing lidocaine 5 percent (Lidoderm) appears to provide significant improvement in both pain intensity and pain relief for patients with painful diabetic neuropathy, researchers reported here December 10th at the clinical meeting of the American Society of Health-System Pharmacists.
The results are important, researchers said, because the condition affects more than 50 percent of elderly patients with diabetes and is notoriously difficult to treat effectively. The lidocaine patch is a targeted peripheral analgesic that has proved effective in treating postherpetic neuralgia.
As such, it may be a potentially powerful strategy for treating painful diabetic neuropathy, according to the researchers, led by Stephanie Hart-Gouleau, MD, of the department of anaesthesiology at the University of Rochester School of Medicine, in Rochester, New York, United States.
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!